Medicine & Life Sciences
Biopsy
7%
Bone and Bones
25%
Breast Neoplasms
11%
Carcinoma
9%
Colorectal Neoplasms
8%
Deoxyglucose
20%
Drug Therapy
13%
Esophageal Neoplasms
23%
fluciclovine F-18
18%
Fluorides
11%
Fluorine-18
9%
Fluorodeoxyglucose F18
75%
Gastrointestinal Stromal Tumors
14%
Glycolysis
12%
Head and Neck Neoplasms
7%
Idoxuridine
9%
Imatinib Mesylate
10%
Liver
9%
Lung
7%
Lung Neoplasms
12%
Lymphoma
15%
Lymphoma, Large B-Cell, Diffuse
10%
Monoclonal Antibodies
8%
Neoplasm Metastasis
29%
Neoplasms
34%
Non-Small Cell Lung Carcinoma
20%
Nuclear Medicine
13%
Positron Emission Tomography Computed Tomography
76%
Positron-Emission Tomography
100%
Progression-Free Survival
11%
Prostate-Specific Antigen
10%
Prostatic Neoplasms
27%
Radiation
8%
Radionuclide Imaging
10%
Radiopharmaceuticals
7%
Radiotherapy
13%
Radium-223
9%
Response Evaluation Criteria in Solid Tumors
9%
Rituximab
9%
Single Photon Emission Computed Tomography Computed Tomography
12%
Single-Photon Emission-Computed Tomography
13%
Sodium Fluoride
14%
Spiral Computed Tomography
6%
Survival
16%
Technetium Tc 99m Medronate
6%
Thallium
6%
Therapeutics
15%
Thyroid Neoplasms
14%
Tomography
20%
Tumor Burden
13%